In a 62‑year‑old man who developed right‑sided muscle twitching after starting fluoxetine and trazodone, which medication is most likely responsible?

Which Medication Is Causing Right-Sided Twitching?

The combination of fluoxetine and trazodone is most likely responsible for the right-sided twitching through excessive serotonergic activity, though either drug alone can cause myoclonus—fluoxetine through serotonin reuptake inhibition and trazodone through 5-HT2 receptor effects, with their interaction substantially increasing risk.

Mechanism of Drug-Induced Myoclonus

Serotonergic Pathway

• Increased serotonergic transmission is the primary mechanism by which multiple antidepressants induce myoclonus (involuntary muscle twitching), with level II evidence supporting this association for cyclic antidepressants and SSRIs 1
• Fluoxetine potently inhibits serotonin reuptake as its primary pharmacological action, leading to increased synaptic serotonin concentrations 2
• Trazodone acts primarily as a 5-HT2/1C receptor antagonist rather than a pure serotonin reuptake inhibitor, though it is commonly mislabeled as such 2

Pharmacokinetic Drug Interaction

• Fluoxetine significantly increases plasma concentrations of both trazodone and its active metabolite meta-chlorophenylpiperazine (mCPP) through CYP450 inhibition, creating a pharmacokinetic interaction that amplifies serotonergic effects 3
• When fluoxetine 20 mg/day is added to trazodone 100 mg/day, there is a significant elevation in plasma levels of both trazodone and mCPP compared to trazodone alone 3
• This combination creates excessive serotonergic activity through multiple mechanisms: fluoxetine's reuptake inhibition plus elevated trazodone/mCPP levels affecting 5-HT2C receptors 3

Clinical Evidence of This Specific Interaction

Case Report Documentation

• A 39-year-old male on trazodone 50 mg nightly developed worsening hand tremors 3 days after fluoxetine 20 mg was added and the trazodone dose increased to 100 mg 4
• The tremor initially appeared at rest but worsened significantly after the combination was initiated, representing drug-induced myoclonus from excessive serotonergic activity 4
• Both medications were discontinued and symptoms completely resolved within 7 days, confirming the drug interaction as the causative factor 4

Individual Drug Contributions

Fluoxetine Alone

• Fluoxetine is metabolized through CYP2D6, and poor metabolizers or those on CYP2D6 inhibitors have substantially elevated drug exposure—3.9-fold higher at 20 mg doses—increasing risk for neurotoxicity including tremors and myoclonus 5
• The FDA has issued safety warnings about fluoxetine's potential for serious adverse events including seizures and metabolic toxicity, particularly at higher doses or in poor metabolizers 5

Trazodone Alone

• Trazodone is associated with higher incidence of somnolence compared to other antidepressants, but myoclonus as a standalone adverse effect is less commonly reported 5
• The drug's primary mechanism through 5-HT2 receptor antagonism differs from typical SSRI-induced myoclonus 2

Clinical Management Algorithm

Immediate Steps

1. Discontinue both fluoxetine and trazodone immediately—drug-induced myoclonus typically resolves after withdrawal of the offending agents, usually within 7 days 4, 1
2. Monitor for resolution of twitching over the next week; persistence beyond 7-10 days warrants neurological evaluation for alternative causes 1

If Antidepressant Treatment Must Continue

• Wait at least 7 days after symptom resolution before restarting any antidepressant 4
• Choose sertraline as a single-agent alternative—it has the lowest propensity for CYP450-mediated drug interactions and is less likely to cause this specific adverse effect compared to fluoxetine 5, 6
• Start sertraline at 50 mg daily (or 25 mg if the patient is anxious about recurrence) and monitor closely for any return of involuntary movements 6

Medications to Avoid

• Do not restart the fluoxetine-trazodone combination, as the interaction is well-documented and predictable 4, 3
• Avoid other serotonergic combinations (SSRI + tramadol, SSRI + triptans, SSRI + other antidepressants) that increase risk for excessive serotonergic activity 6
• Never combine with MAOIs due to severe serotonin syndrome risk 6

Critical Safety Monitoring

Serotonin Syndrome Vigilance

• While myoclonus alone may represent a mild serotonergic adverse effect, monitor for progression to full serotonin syndrome: mental status changes (confusion, agitation), neuromuscular hyperactivity (clonus, hyperreflexia), and autonomic instability (hypertension, tachycardia, diaphoresis) 6
• Serotonin syndrome is a medical emergency requiring immediate discontinuation of all serotonergic agents and supportive care 6

Common Pitfall to Avoid

• Do not attribute the twitching solely to anxiety or stress—the temporal relationship to medication initiation/dose increase and the documented pharmacokinetic interaction make drug-induced myoclonus the most likely diagnosis 4
• Do not simply reduce doses while continuing both medications; the interaction persists even at lower doses due to fluoxetine's inhibition of trazodone metabolism 3